Semaglutide is one of the most-recognized compounds in the GLP research category and a common reference point in metabolic research.
Classification
Semaglutide is a GLP-1 receptor agonist — a single-target compound. A fatty-acid (C18) modification extends its half-life to roughly seven days in research characterizations, which is part of why it is so widely studied. For how it differs from dual and triple agonists, see the GLP category overview.
In research
It is studied in incretin-pathway and metabolic research as a single-receptor baseline. As with every compound here, this is mechanism for research reference — not a statement about outcomes.
Specifications & verification
Supplied as a 10mg lyophilized vial to a ≥99% purity standard; store at -20°C. Each batch ships with an independent, lot-matched HPLC COA (current lot CS-se101128) you can verify yourself.
Semaglutide is a research reference material for laboratory research use only. Not for human consumption.